Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://en.prnasia.com/releases/global/us-fda-study-may-proceed-letter-for-clarity-s-cu-64-sar-bispsma-trial-in-prostate-cancer-350783.shtml
Feb 7, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next